Free Newsletter
ALSO NOTED: States sued over prescription-tracking law; Watson challenges Warner Chilcott on birth control pill;
> Three health information companies are suing the states of Vermont and Maine to block laws that would prevent drug makers from tracking individual scrips written by individual doctors; the privacy laws are set to take effect January 1. Release
> Watson Pharmaceuticals has asked the FDA to approve its copycat of Femcon, a Warner Chilcott birth-control pill; Warner Chilcott, meanwhile, sued the generics maker to block the drug. Release
> Contract manufacturer SAFC says it's planning to add conjugation capabilities to its Missouri plant, aiming to target pharma clients developing novel anti-cancer drugs. Report
> The troubled PDL BioPharma has put out the 'for sale' sign in an attempt to find a buyer for the company as a whole or of its key assets. Report
> Perlegen Sciences and Roche's 454 Life Sciences have teamed up to conduct large scale genetic re-sequencing in DNA samples collected from people with specific responses to an undisclosed class of drug. Report
And Finally... Antibiotics might fight stroke, too: A small new study showed that minocycline administered within 24 hours of a stroke reduced brain damage and physical impairment. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: